1. Forty-third Report Presented By: Swati Sarin ICRI, Dehradun 2. World Health Organization (WHO) was established in 1948 as a specialized agency of United Nations serving…

Slide 11 MDG Target 8.E gap analysis Dr Hans Hogerzeil Director, Department of Essential Medicines and Pharmaceutical Policies, World Health Organization October 2008 Slide…

Slide 1The WHO Medicines Strategy 2008-2013 Richard Laing Based on materials produced by Hans V. Hogerzeil, Essential Medicines and Pharmaceutical Policies November 2011…

1.WHO guidelinesfor the management ofpostpartum haemorrhageand retained placenta2. WHO guidelinesfor the management ofpostpartum haemorrhageand retained placenta 3. WHO Library…

1. Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 1 Third International Conference for Improving Use of Medicines (ICIUM2011): Informed Strategies,…

1. The leading IP Group in Spanish and Portuguese speaking countries PATENT PROSECUTION STRATEGY IN BRAZIL Igor Simões 2. © 2011 Clarke, Modet & Cº BRAZIL 3. © 2011…

WHO/EMP/QSM/2011.3 The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances 2011 WHO/EMP/QSM/2011.3 The use of stems in…

Slide 1 WHO Good Governance for Medicines programme Technical Briefing Seminar 19 November 2009, Geneva Dr Guitelle Baghdadi-Sabeti Department of Essential Medicines and…

Slide 1WHO Prequalification of Medicines Programme Raul Kiivet, MD, PhD Manager, Prequalification of Medicines Programme Quality Assurance and Safety: Medicines (QSM) Department…

Slide 1 3rd Baltic Conference on Medicines Economic Evaluation, Reimbursement and Rational Use of Pharmaceuticals Pricing and Reimbursement of Pharmaceuticals in Baltic Countries…